Zobrazeno 1 - 10
of 483
pro vyhledávání: '"G. Caleb Alexander"'
Publikováno v:
AJPM Focus, Vol 3, Iss 2, Pp 100200- (2024)
Introduction: The use of race in clinical risk prediction tools may exacerbate racial disparities in healthcare access and outcomes. This study quantified the number of individuals reclassified for primary prevention of cardiovascular disease owing t
Externí odkaz:
https://doaj.org/article/680da4117025441abc478f7358908227
Autor:
Alexander R. Zheutlin, Nasser Sharareh, Jenny S. Guadamuz, Ransmond O. Berchie, Catherine G. Derington, Joshua A. Jacobs, Favel L. Mondesir, G. Caleb Alexander, Emily B. Levitan, Monika Safford, Robert O. Vos, Dima M. Qato, Adam P. Bress
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background Poor neighborhood‐level access to health care, including community pharmacies, contributes to cardiovascular disparities in the United States. The authors quantified the association between pharmacy proximity, antihypertensive and statin
Externí odkaz:
https://doaj.org/article/b9b50bd1dca2489399c69580e1c71e23
Publikováno v:
American Heart Journal Plus, Vol 38, Iss , Pp 100359- (2024)
Background: Prasugrel, first approved in 2009, was subject to a US Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) to mitigate the risk of bleeding associated with its use. Methods: We performed a narrative review of
Externí odkaz:
https://doaj.org/article/222045da3df64439988bc8a5960b0467
Autor:
Justin T. Reese, Hannah Blau, Elena Casiraghi, Timothy Bergquist, Johanna J. Loomba, Tiffany J. Callahan, Bryan Laraway, Corneliu Antonescu, Ben Coleman, Michael Gargano, Kenneth J. Wilkins, Luca Cappelletti, Tommaso Fontana, Nariman Ammar, Blessy Antony, T.M. Murali, J. Harry Caufield, Guy Karlebach, Julie A. McMurry, Andrew Williams, Richard Moffitt, Jineta Banerjee, Anthony E. Solomonides, Hannah Davis, Kristin Kostka, Giorgio Valentini, David Sahner, Christopher G. Chute, Charisse Madlock-Brown, Melissa A. Haendel, Peter N. Robinson, Heidi Spratt, Shyam Visweswaran, Joseph Eugene Flack, IV, Yun Jae Yoo, Davera Gabriel, G. Caleb Alexander, Hemalkumar B. Mehta, Feifan Liu, Robert T. Miller, Rachel Wong, Elaine L. Hill, Lorna E. Thorpe, Jasmin Divers
Publikováno v:
EBioMedicine, Vol 87, Iss , Pp 104413- (2023)
Summary: Background: Stratification of patients with post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID) would allow precision clinical management strategies. However, long COVID is incompletely understood and characterised by a wide ra
Externí odkaz:
https://doaj.org/article/f4635ea98874437da59d335d9ba0de7a
Autor:
Sheriza Baksh, Jiajun Wen, Omar Mansour, Hsien-Yen Chang, Mara McAdams-DeMarco, Jodi B. Segal, Stephan Ehrhardt, G. Caleb Alexander
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Clinical trials investigating cardiovascular safety of dipeptidyl peptidase-IV inhibitors (DPP-4i) among patients with cardiovascular and renal disease rarely recruit patients with renal impairment, despite associations with increased risk f
Externí odkaz:
https://doaj.org/article/a638a7a3df1f45569c97db45d9e14c45
Autor:
Kathleen M. Andersen, Corey S. Joseph, Hemalkumar B. Mehta, Michael B. Streiff, Joshua F. Betz, Robert C. Bollinger Jr, Arielle M. Fisher, Amita Gupta, Charles F. LeMaistre, Matthew L. Robinson, Yanxun Xu, Derek K. Ng, G. Caleb Alexander, Brian T. Garibaldi
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Background and Objectives Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standar
Externí odkaz:
https://doaj.org/article/84624ad9ddef4f7eb984ace062ba3ac1
Autor:
Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 9 (2022)
Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) mitigate cardiovascular risk in individuals with type 2 diabetes, but most eligible patients do not receive them. We cha
Externí odkaz:
https://doaj.org/article/54e819014e4549dc8a35d0dce0097b46
Autor:
Matthew Daubresse, G. Caleb Alexander, Deidra C. Crews, Dorry L. Segev, Krista Lentine, Mara A. McAdams-DeMarco
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Individuals undergoing hemodialysis in the United States frequently report pain and receive three-fold more opioid prescriptions than the general population. While opioid use is appropriate for select patients, high-dose utilizati
Externí odkaz:
https://doaj.org/article/9defb7dcd61d435b84b783a16497c98f
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories
Externí odkaz:
https://doaj.org/article/5a191755a9304d1899e4870a5abe9bb3
Autor:
Evan Mayo-Wilson, James Heyward, Anthony Keyes, Jesse Reynolds, Sarah White, Nidhi Atri, G. Caleb Alexander, Audrey Omar, Daniel E. Ford, on behalf of the National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-13 (2018)
Abstract Background Many clinical trials conducted by academic organizations are not published, or are not published completely. Following the US Food and Drug Administration Amendments Act of 2007, “The Final Rule” (compliance date April 18, 201
Externí odkaz:
https://doaj.org/article/bcb72671c9aa480aa84078d401041e37